Regulation of Adenylyl Cyclase Type V/VI in Smooth Muscle: Interplay of Inhibitory G Protein and Ca2+ Influx

Abstract

The characteristics of inhibitory regulation of adenylyl cyclase V/VI by Ca2+ and G proteins were examined in dispersed gastric smooth muscle cells. The mechanisms were evoked separately, sequentially, or concurrently using ligand-gated and G protein-coupled receptor agonists and receptor-independent probes (e.g, thapsigargin). During the initial phase of agonist stimulation, α,β-methylene-ATP, UTP, and ATP inhibited forskolin-stimulated cAMP formation in a concentration-dependent fashion. Inhibition by α,β-methylene-ATP, which activates ligand-gated P2X receptors, was abolished by zero Ca2+, whereas inhibition by UTP, which activates P2Y2 receptors coupled to Gq/11 and Gi3, was not affected by zero Ca2+ but was abolished by pertussis toxin (PTX). Inhibition by ATP, which activates both P2X and P2Y2 receptors, was not affected by zero Ca2+ alone; but after inhibition mediated by Gαi3 was blocked with PTX, inhibition by Ca2+influx was unmasked and was abolished by zero Ca2+. Inhibition by cholecystokinin-8 was observed only during the phase of capacitative Ca2+ influx and was blocked by zero Ca2+. Inhibition by UTP during this phase was not affected by zero Ca2+ alone; but after inhibition mediated by Gαi3 was blocked with PTX, inhibition by Ca2+influx was unmasked and was abolished by zero Ca2+. Inhibition of adenylyl cyclase V/VI activity in smooth muscle can be mediated independently by inhibitory G proteins and Ca2+influx but is exclusively mediated by inhibitory G proteins when both mechanisms are triggered.

Footnotes

  • Send reprint requests to: G. M. Makhlouf, M.D., Ph.D., P.O. Box 980711, Medical College of Virginia, Richmond, VA 23298-0711.

  • This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK28300.

  • Abbreviations:
    IP3
    inositol triphosphate
    PTX
    pertussis toxin
    CCK-8
    cholecystokinin octapeptide
    PLC
    phospholipase C
    [Ca2+]i
    intracellular Ca2+ concentration
    PDE
    phosphodiesterase
    EGTA
    ethylene glycol bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid
    HEPES
    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
    • Received December 12, 1997.
    • Accepted March 17, 1998.
« Previous | Next Article »Table of Contents